Streetbeat News

Analyst Ratings

AZN

BAYRY

AstraZeneca has released updated results from the HIMALAYA Phase 3 trial evaluating Imfinzi plus Imjudo in unresectable hepatocellular carcinoma patients. The data shows that the treatment reduced the risk of death by 22% compared to Bayer's Nexavar. The safety profile was consistent with known profiles and no new safety signals were observed. AstraZeneca's shares are down 0.16% at $70.85.

Portfolio Pulse from Vandana Singh

June 29, 2023 | 5:41 pm

CHTR

A significant investor has taken a bearish stance on Charter Communications (NASDAQ:CHTR), with 62% of recent trades being bearish and 37% bullish. The total amount for puts is $629,840 and for calls is $133,052. Whales have been targeting a price range from $200.0 to $390.0 for Charter Communications over the last 3 months. The current price of CHTR is up 0.38% at $360.77.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 5:40 pm

CSCO

A whale investor has taken a bullish stance on Cisco Systems (NASDAQ:CSCO), with 50% of investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $40.0 to $57.5 for Cisco Systems over the last 3 months. The price of CSCO is up 0.49% at $51.12, with RSI indicators suggesting the stock may be approaching overbought. Next earnings are expected to be released in 48 days.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 5:39 pm

COST

Telsey Advisory Group analyst Joseph Feldman reiterated an Outperform rating on Costco Wholesale Corporation (NASDAQ:COST) with a price target of $540. He expects Costco's June sales to be negatively impacted by a decrease in gas prices and less spending on discretionary items. Despite this, Feldman believes Costco will remain a share gainer due to its value-focused merchandising and high member loyalty.

Portfolio Pulse from Shivani Kumaresan

June 29, 2023 | 5:37 pm

XPOF

Morgan Stanley analyst Brian Harbour reiterated an Overweight rating on Xponential Fitness, Inc. (NYSE:XPOF), with a price target of $32. The analyst praised the company's solid record of license sales and unit openings, which has generally led to revenue and EBITDA beats. XPOF recently responded to a short-seller report, reiterating the business's strength and its franchisees' health. The company's shares are trading higher by 3.44% to $17.72.

Portfolio Pulse from Nabaparna Bhattacharya

June 29, 2023 | 5:34 pm

WISH

Loop Capital has downgraded ContextLogic's stock from Hold to Sell and set a price target of $7. This has led to a decrease in ContextLogic's share price.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 5:27 pm

TRMLF

National Bank Financial Inc's analyst Dan Payne has maintained an 'Outperform' rating on Tourmaline Oil (OTC:TRMLF) but lowered the price target from C$80 to C$75.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 5:26 pm

SU

National Bank Financial Inc's analyst Travis Wood has maintained an 'Outperform' rating on Suncor Energy (NYSE:SU) but lowered the price target from C$60 to C$57.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 5:24 pm

PREKF

National Bank Financial Inc's analyst Dan Payne has maintained a 'Sector Perform' rating on PrairieSky Royalty (OTC:PREKF) and raised the price target from C$23 to C$26.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 5:22 pm

RETA

Reata Pharmaceuticals' shares are trading higher following the FDA's approval of the Prior Approval Supplement to update the drug substance specification for SKYCLARYS. Ladenburg Thalmann has also increased its price target for the company from $104 to $122.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 5:21 pm